文献速递急性肾损伤

IL-6介导肝细胞产生是急性肾损伤时血浆和尿NGAL的主要来源

IL-6-mediated hepatocyte production is the primary source of plasma and urine neutrophil gelatinase-associated lipocalin during acute kidney injury.
PubMed 文献 · Kidney Int · 2019-11-28

研究探讨IL-6在肾脏及肾外NGAL产生中的作用。缺血性AKI野生型小鼠血浆IL-6、肝NGAL mRNA、血浆及尿NGAL均升高,IL-6敲除后均降低;静脉给IL-6可升高正常小鼠上述指标;肝细胞特异性NGAL敲除后缺血性AKI小鼠血浆和尿NGAL降低;静脉重组人NGAL在近端小管功能障碍时出现于尿,肾前性氮质血症时不出现。结论:AKI时IL-6介导肝细胞产生NGAL,肝细胞是血浆和尿NGAL的主要来源,血浆NGAL在近端小管功能障碍时进入尿。

要点

  • AKI时肝细胞是血浆和尿NGAL的主要来源,并非仅肾小管特异性标志物。
  • IL-6介导肝细胞NGAL产生,IL-6敲除或肝细胞NGAL敲除可降低血浆和尿NGAL。
  • 血浆NGAL在近端小管功能障碍时进入尿,肾前性氮质血症时不出现。

核心结论

  • AKI时IL-6介导肝细胞产生NGAL,肝细胞是血浆和尿NGAL的主要来源。
  • 血浆NGAL在近端小管功能障碍时出现于尿,提示NGAL作为AKI标志物的解读需改变。

研究设计与样本

  • 野生型小鼠缺血性AKI模型,比较IL-6敲除、静脉IL-6、肝细胞特异性NGAL敲除及静脉重组人NGAL后的NGAL变化。

主要发现

  • 野生型小鼠缺血性AKI后血浆IL-6、肝NGAL mRNA、血浆NGAL和尿NGAL均升高,IL-6敲除小鼠上述指标均降低。
  • 正常小鼠静脉给予IL-6后肝NGAL mRNA、血浆NGAL和尿NGAL升高。
  • 肝细胞特异性NGAL敲除小鼠缺血性AKI后肝NGAL mRNA缺失,血浆和尿NGAL降低。
  • 静脉重组人NGAL后,近端小管功能障碍时小鼠尿中可检测到人NGAL,肾前性氮质血症时未检测到。

临床怎么用

  • 解读AKI时NGAL升高需考虑肝细胞来源及IL-6介导的全身反应,不应仅视为肾小管损伤特异性标志。
  • 尿NGAL升高可能反映血浆NGAL经近端小管功能障碍漏出,需结合肾前性因素鉴别。

局限性

  • 研究基于小鼠模型,人体临床验证未在原文摘要中报告。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Neutrophil gelatinase associated lipocalin (NGAL, Lcn2) is the most widely studied biomarker of acute kidney injury (AKI). Previous studies have demonstrated that NGAL is produced by the kidney and released into the urine and plasma. Consequently, NGAL is currently considered a tubule specific injury marker of AKI. However, the utility of NGAL to predict AKI has been variable suggesting that other mechanisms of production are present. IL-6 is a proinflammatory cytokine increased in plasma by two hours of AKI and mediates distant organ effects. Herein, we investigated the role of IL-6 in renal and extra-renal NGAL production. Wild type mice with ischemic AKI had increased plasma IL-6, increased hepatic NGAL mRNA, increased plasma NGAL, and increased urine NGAL; all reduced in IL-6 knockout mice. Intravenous IL-6 in normal mice increased hepatic NGAL mRNA, plasma NGAL and urine NGAL. In mice with hepatocyte specific NGAL deletion (Lcn2hep-/-) and ischemic AKI, hepatic NGAL mRNA was absent, and plasma and urine NGAL were reduced. Since urine NGAL levels appear to be dependent on plasma levels, the renal handling of circulating NGAL was examined using recombinant human NGAL. After intravenous recombinant human NGAL administration to mice, human NGAL in mouse urine was detected by ELISA during proximal tubular dysfunction, but not in pre-renal azotemia. Thus, during AKI, IL-6 mediates hepatic NGAL production, hepatocytes are the primary source of plasma and urine NGAL, and plasma NGAL appears in the urine during proximal tubule dysfunction. Hence, our data change the paradigm by which NGAL should be interpreted as a biomarker of AKI.

来源:Kidney Int,查看原文。版权归原作者所有。

引用

  1. Skrypnyk NI, Gist KM, Okamura K, et al. IL-6-mediated hepatocyte production is the primary source of plasma and urine neutrophil gelatinase-associated lipocalin during acute kidney injury. Kidney Int. 2019. PMID: 32081304. doi:10.1016/j.kint.2019.11.013

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。